You just read:

Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) for Resolution of Multiple Sclerosis Relapse in a U.S. Health Plan Population

News provided by

Mallinckrodt plc

Nov 07, 2019, 06:45 ET